Incannex Healthcare Inc. Quarterly Update, Q1 2024

MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Inc. (NASDAQ: IXHL), ('Incannex' or the 'Company'), is pleased to prov

GlobeNewswireApr 16 20:00

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 14:37

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence

Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant DepressionPartners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a P

BenzingaMar 30 00:43

Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado

Recent advancements within the field of mental health with the use of psilocybin-assisted therapy, as well as Colorado's forward-thinking legislation about this therapy, have proven exciting.Psilocybi

BenzingaMar 22 23:05

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More

FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private PlacementClinical-stage psychedelics biopharma c

BenzingaMar 21 02:49

Incannex Healthcare Appoints New CFO and Secretary

InvestingMar 5 20:12